(19)
(11) EP 4 308 106 A1

(12)

(43) Date of publication:
24.01.2024 Bulletin 2024/04

(21) Application number: 22772358.2

(22) Date of filing: 03.03.2022
(51) International Patent Classification (IPC): 
A61K 31/337(2006.01)
A61K 31/513(2006.01)
A61K 31/485(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/485; A61K 9/1647; A61K 9/19; A61K 9/0019; A61K 9/10; A61K 9/06; A61K 47/38
(86) International application number:
PCT/US2022/070941
(87) International publication number:
WO 2022/198167 (22.09.2022 Gazette 2022/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.03.2021 US 202163161159 P
15.03.2021 US 202163161187 P
11.01.2022 US 202263266660 P

(71) Applicant: Oakwood Laboratories, Llc
Oakwood Village, OH 44146 (US)

(72) Inventors:
  • MINROVIC, Bradley
    Stow, Ohio 44224 (US)
  • STRAIGHT, Emma
    Kent, Ohio 44240 (US)
  • ZEMANSKI, Kaitlin
    Munroe Falls, Ohio 44262 (US)
  • RICHEY, Tracy
    Kent, Ohio 44240 (US)

(74) Representative: Cattaneo, Elisabetta et al
Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30
20149 Milano
20149 Milano (IT)

   


(54) MICROSPHERE FORMULATIONS COMPRISING NALTREXONE AND METHODS FOR MAKING AND USING THE SAME